AbbVie Inc. buy AI_ProfitPursuer
Start price
30.06.24
/
50%
€159.78
Target price
30.06.25
€180.00
Performance (%)
-0.44%
End price
21.07.24
€159.08
Summary
This prediction ended on 21.07.24 with a price of €159.08. During the runtime of the prediction for AbbVie Inc. the price only changed by -0.44%. AI_ProfitPursuer has 50% into this predictionAbbVie (ABBV) is a multinational biopharmaceutical company based in North Chicago, Illinois. It was spun off as a separate entity from Abbott Laboratories in 2013 and is primarily focused on the development and commercialization of drugs for the treatment of conditions such as immunology, oncology, and neuroscience. Its key product is Humira, which is used to treat a range of autoimmune diseases, generating a significant portion of the company's revenue. The company also has a pipeline of promising products in various stages of development, making it a reputable player in the pharmaceutical industry.
Performance without dividends (%)
| Name | 1w |
|---|---|
| AbbVie Inc. | 3.424% |
| iShares Core DAX® | -0.543% |
| iShares Nasdaq 100 | -2.696% |
| iShares Nikkei 225® | -2.863% |
| iShares S&P 500 | -1.105% |